We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Walmart Inc | NYSE:WMT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.44 | 60.58 | 60.16 | 60.53 | 12,360,489 | 00:59:59 |
Where: Walmart Supercenter | 939 N Dupont Boulevard, Milford, DE 19963When: April 20, 2024, from 11 a.m. to 3 p.m.
Who: Celebrities, state, and local elected officials
Basketball legend and WNBA superstar Sheryl Swoopes, a spokesperson for RadNet's nationwide cancer screening program, will attend the event in Milford on Saturday. This collaboration aims to raise awareness of the benefits of screening, with an emphasis on health equity and improving access to high-quality care.
“Reflecting on my journey, I've come to appreciate the profound impact accessible healthcare services can have on local communities. Growing up in a small town similar to Milford, I recognize the critical importance of readily available screening services,” said Swoopes. “I’m proud to lend my voice to this important initiative and am committed to advocating for underserved communities to have increased access to life-saving preventive care.”
"With the support of Sheryl Swoopes, our MammogramNow initiative will help those women without access to breast cancer screening services to receive their annual screening mammograms. I believe that this initiative will ultimately save lives,” said Dr. Howard Berger, CEO and Founder of RadNet.
For more information on the Saturday event, or on RadNet’s nationwide screening initiative, please visit http://www.radnet.com/delaware-imaging-network/ or visit the Walmart Supercenter in Milford, Delaware.
Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements, including statements regarding the capabilities of the DeepHealth® technology, the DeepHealth® Enhanced Breast Cancer Detection service (EBCD) and the success of the pilot program with MammogramNow or any expansion of the program beyond the pilot, are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods.
Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.
For media inquiries or further information, please contact:Jackson GaskinsJgaskins@hotpaperlantern.com
About RadNet, Inc.RadNet, Inc., is the leading national provider of free-standing, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 366 owned and/or operated outpatient imaging centers. RadNet's markets include California, Maryland, Delaware, New Jersey, New York, Florida, and Arizona. Together with affiliated radiologists, including full-time and per diem employees and technologists, RadNet has over 9,000 employees. For more information, visit http://www.radnet.com.
About MammogramNow™ MammogramNow is a proactive breast cancer screening program hosted at select locations. By leveraging cutting-edge technology and artificial intelligence along with the convenience of retail spaces, the program aims to increase accessibility to screening mammography, so that women are empowered to prioritize their well-being.
About Walmart Walmart Inc. (NYSE: WMT) helps people around the world save money and live better—anytime and anywhere—in retail stores, online, and through their mobile devices. Each week, nearly 230 million customers and members visit approximately 10,800 stores and clubs under 51 banners in 25 countries and eCommerce websites. With fiscal year 2022 revenue of $559 billion, Walmart employs over 2.3 million associates worldwide.
1 Year Walmart Chart |
1 Month Walmart Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions